William Duke
Director of Finance/CFO chez INVIVYD, INC.
Fortune : - $ au 31/03/2024
Profil
William E.
Duke is currently the Chief Financial & Accounting Officer at Invivyd, Inc. Prior to this, he held various financial positions at companies such as Haemonetics Corp., Genzyme Corp., g8wave Holdings, Inc., OTF Group, Inc., Valeritas, Inc., Pulmatrix, Inc., Kaleido Biosciences, Inc., and Apexigen, Inc. He has an MBA from Bentley University and an undergraduate degree from Stonehill College, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INVIVYD, INC.
-.--% | 18/12/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de William Duke
| Sociétés | Poste | Début |
|---|---|---|
| INVIVYD, INC. | Director of Finance/CFO | 01/09/2023 |
Anciens postes connus de William Duke
| Sociétés | Poste | Fin |
|---|---|---|
| APEXIGEN, INC. | Director of Finance/CFO | 23/08/2023 |
| KALEIDO BIOSCIENCES, INC. | Director of Finance/CFO | 08/04/2022 |
| PULMATRIX, INC. | Director of Finance/CFO | 22/11/2019 |
| VALERITAS INC | Director of Finance/CFO | 01/06/2015 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Director of Finance/CFO | - |
Formation de William Duke
| Bentley University | Masters Business Admin |
| Stonehill College, Inc. | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| HAEMONETICS CORPORATION | Health Technology |
| PULMATRIX, INC. | Health Technology |
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| APEXIGEN, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| g8wave Holdings, Inc. | Communications |
OTF Group, Inc.
 OTF Group, Inc. Miscellaneous Commercial ServicesCommercial Services OTF Group, Inc. provided management consulting services. The company was founded in 2000 and was headquartered in Belmont, MA. | Commercial Services |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Valeritas, Inc. engages in the development and commercialization of drug delivery solutions for the treatment of diabetes. Its product, V-Go wearable insulin delivery device, which enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery by using one type of insulin at a continuous preset basal rate over a 24-hour period and provides on-demand bolus dosing for meals and snacks. The company was founded on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |
